Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Classifica tra le azioni #199
GSK plc, together with its subsidiaries, engages in the creation, discovery,... GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Prezzo delle azioni
$51.99
Capitalizzazione di mercato
$104.42B
Variazione (1 giorno)
0.29%
Variazione (1 anno)
32.49%
Paese
GB
Scambia GSK plc (GSK)

Categoria

Ricavi di GSK plc (GSK)
Ricavi nel Dec 2025 TTM: $43.93B
Secondo gli ultimi rapporti finanziari di GSK plc, i ricavi attuali dell'azienda (TTM) sono pari a $43.93B. Nel 2024, l'azienda ha registrato ricavi di $39.37B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $38.61B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per GSK plc da 2000 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $43.93B 2.24%
2025 $42.97B 9.13%
2024 $39.37B 1.98%
2023 $38.61B 8.83%
2022 $35.48B 6.25%
2021 $33.39B 0.28%
2020 $33.30B -25.61%
2019 $44.76B 14.02%
2018 $39.26B -3.77%
2017 $40.79B 18.52%
2016 $34.42B -2.36%
2015 $35.25B -1.64%
2014 $35.84B -18.35%
2013 $43.90B 2.38%
2012 $42.87B 0.88%
2011 $42.50B -3.83%
2010 $44.19B -3.75%
2009 $45.91B 29.14%
2008 $35.55B -21.53%
2007 $45.31B -0.48%
2006 $45.53B 22.17%
2005 $37.27B -2.94%
2004 $38.40B 0.32%
2003 $38.27B 12.00%
2002 $34.17B 14.47%
2001 $29.85B 10.60%
2000 $26.99B 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$65.18B 48.37%
US
$58.74B 33.71%
GB
$94.19B 114.42%
US
$61.16B 39.22%
US
$56.15B 27.82%
CH